Association between diabetes complications and leukocyte counts in Iranian patients

References

• American Diabetes AssociationStandards of medical care in diabetes – 2011Diabetes Care201134Suppl 1S116121193625
   PubMed Web of Science ®Google Scholar
• DandonaPAljadaAA rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosisAm J Cardiol2002905A27G33G
   PubMed Web of Science ®Google Scholar
• KingHAubertREHermanWHGlobal burden of diabetes, 1995–2025 prevalence, numerical estimates, and projectionsDiabetes Care1998219141414319727886
   PubMed Web of Science ®Google Scholar
• JohnstonSSConnerCAagrenMSmithDMBouchardJBrettJEvidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetesDiabetes Care20113451164117021421802
   PubMed Web of Science ®Google Scholar
• BunceCWormaldRCauses of blind certifications in England and WalesEye200822790591117332762
   PubMed Web of Science ®Google Scholar
• AvisarRFrilingRSnirMAvisarIWeinbergerDEstimation of prevalence and incidence rates and causes of blindness in Israel, 1998–2003Isr Med Assoc J200681288088117214111
   PubMed Web of Science ®Google Scholar
• CusumanoAGarcia-GarciaGDi GioiaCEnd-stage renal disease and its treatment in Latin America in the twenty-first centuryRen Fail200628863163717162420
   PubMed Web of Science ®Google Scholar
• InsullWJrThe pathology of atherosclerosis: plaque development and plaque responses to medical treatmentAm J Med2009122Suppl 1S31419110086
   PubMed Web of Science ®Google Scholar
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)UK Prospective Diabetes Study (UKPDS) GroupLancet199835291318378539742976
   PubMed Web of Science ®Google Scholar
• The diabetes control and complications trial research group: The effect of intensive treatment of diabetes on development and progression of long term complications in insulin dependent diabetes mellitusN Eng J Med199332914997986
   Web of Science ®Google Scholar
• StamlerJVaccaroONeatonJDWentworthDDiabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialDiabetes Care19931624344448432214
   PubMed Web of Science ®Google Scholar
• RossRAtherosclerosis-an inflammatory diseaseN Engl J Med1999340241151269887164
   PubMed Web of Science ®Google Scholar
• WeijenbergMPFeskensEJKromhoutDWhite blood cell count and the risk of coronary heart disease and all-cause mortality in elderly menArterioscler Thromb Vasc Biol19961644995038624770
   PubMed Web of Science ®Google Scholar
• TongPCLeeKFSoWYWhite blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetesDiabetes Care200427121622214693992
   PubMed Web of Science ®Google Scholar
• HeidlandASebekovaKSchinzelRAdvanced glycation end products and the progressive course of renal diseaseAm J Kidney Dis2001384S10010611576932
   PubMed Web of Science ®Google Scholar
• VlassaraHFuhHDonnellyTCybulskyMAdvanced glycation end products promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbitsMol Med1995144474568521302
   PubMed Web of Science ®Google Scholar
• VlassaraHBrownleeMManogueKRDinarelloCAPasagianACachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelingScience19882404858154615483259727
   PubMed Web of Science ®Google Scholar
• EspositoCGerlachHBrettJSternDVlassaraHEndothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant propertiesJ Exp Med19891704138714072551990
   PubMed Web of Science ®Google Scholar
• AndersenJUMauricioDKarlsenAEMandrup-PoulsenTNielsenJHNerupJInterleukin-1B-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-1-methylxanthineEur J Endocrinol199613422512598630528
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationDiagnosis and classification of diabetes mellitusDiabetes Care201033Suppl 1S626920042775
   PubMed Web of Science ®Google Scholar
• StrejaDCresseyPRabkinSWAssociations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitusJ Diabetes Complications200317312012712738395
   PubMed Web of Science ®Google Scholar
• KangESKimHJAhnCWRelationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetesDiabetes Res Clin Pract200569215115916005364
   PubMed Web of Science ®Google Scholar
• HanleyAJKarterAJFestaAFactor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis StudyDiabetes20025182642264712145182
   PubMed Web of Science ®Google Scholar
• ChealKLAbbasiFLamendolaCMcLaughlinTReavenGMFordESRelationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndromeDiabetes20045351195120015111486
   PubMed Web of Science ®Google Scholar
• CarrDBUtzschneiderKMHullRLIntra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndromeDiabetes20045382087209415277390
   PubMed Web of Science ®Google Scholar
• BoMMassaiaMRaspoSPredictive factors of in-hospital mortality in older patients admitted to a medical intensive care unitJ Am Geriatr Soc200351452953312657074
   PubMed Web of Science ®Google Scholar
• ChungFMTsaiJCChangDMShinSJLeeYJPeripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosisDiabetes Care20052871710171715983324
   PubMed Web of Science ®Google Scholar
• TsaiJCSheuSHChiuHCAssociation of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitusDiabetes Metab Res Rev200723211111816703635
   PubMed Web of Science ®Google Scholar
• FestaAD’AgostinoRJrHowardGMykkänenLTracyRPHaffnerSMChronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS)Circulation20001021424710880413
   PubMed Web of Science ®Google Scholar
• FröhlichMImhofABergGAssociation between C-reactive protein and features of the metabolic syndrome: a population-based studyDiabetes Care200023121835183911128362
   PubMed Web of Science ®Google Scholar
• PécsvarádyZFisherTCDarwinCHDecreased polymorphonuclear leukocyte deformability in NIDDMDiabetes Care199417157638112190
   PubMed Web of Science ®Google Scholar
• Alba-LoureiroTCMunhozCDMartinsJONeutrophil function and metabolism in individuals with diabetes mellitusBraz J Med Biol Res20074081037104417665039
   PubMed Web of Science ®Google Scholar
• StegengaMEVander CrabbenSNDessingMCEffect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humansDiabet Med200825215716418290856
   PubMed Web of Science ®Google Scholar